Microbiology and Biotechnology Letters (한국미생물·생명공학회지)

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Current Status and Perspectives of Cell Culture-Based Vaccine Production

동물세포배양을 통한 백신 생산의 현황과 미래전망

  • Jang, Jun-O (Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University) ;
  • Kim, Ik-Hwan (Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University)
  • Received : 2010.03.16
  • Accepted : 1900.01.21
  • Published : 2010.06.28
Download PDF
⟨ Previous Next ⟩

Abstract

Vaccines, especially for viruses, have been produced from egg-based manufacturing process. The method is simple and easy to set up the manufacturing process. However, the method has many problems in quality control, limit of manufacturing capacity, and ethical issues. Over the last decade, an alternative method, which manufactures vaccines using cell culture-based system, has received great attention to overcome the problems in egg-based vaccine production. This article examines current status and perspectives of cell culture-based vaccine production.

Keywords

References

  1. http://www.who.int/csr/don/2010_01_22/en/index.html
  2. http://flu.cdc.go.kr
  3. http://news.mt.co.kr/mtview.php?no=2009102114341721199&type=1
  4. http://www.cbs.co.kr/nocut/Show.asp?IDX=1330791
  5. http://www.mt.co.kr/view/mtview.php?type=1&no=2009082313244440577&outlink=1
  6. Complete list of vaccines licensed for immunization and distribution in the US (http://www.fda.gov/Biologics BloodVaccines/Vaccines/ApprovedProducts/ucm093833.htm)
  7. 백신 안전사용을 위한 핸드북. 2009. 식약청.
  8. cGMP 총론. 이정길. 2006. 고려대학교한국바이오산업협회
  9. Jeffrey, B. U., Ulrich, V., and Rino, R. 2006. Vaccine manufacturing: challenges and solutions. Nature Biotechnol. 24, 1377-1383. https://doi.org/10.1038/nbt1261
  10. Copier, J., Ward, S., and Dalgleish, A. 2007. Cell based cancer vaccines: Regulatory and commercial development. Vaccine 25S, B35-46.
  11. http://wake.mync.com/site/wake/news/story/44890/
  12. 심층정보분석보고서 - 백신. 2002. 한국과학기술정보연구원(KISTI)
  13. Pham, P. L., Kamen, A., and Durocher, Y. 2006. Large-scale transfection of mammalian cells for the fast production of recombinant protein. Mol. Biotechnol. 34, 225-237. https://doi.org/10.1385/MB:34:2:225
  14. Cox, M. M., Patriarca, P. A., and Treanor, J. 2008. FluBlok, a recombinant hemagglutinin influenza vaccine. Influenza Other Respi. Viruses 2, 211-219. https://doi.org/10.1111/j.1750-2659.2008.00053.x
  15. Grillberger, L., Kreil, T. R., Nasr, S., and Reiter, M. 2009. Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells. Biotechnol. J. 4, 186-201. https://doi.org/10.1002/biot.200800241
  16. Hacker, D. L., de Jesus, M., and Wurm, F. M. 2009. 25 years of recombinant proteins from reactor-grown cells – where do we go from here? Biotechnol. Adv. 27, 1023-1027. https://doi.org/10.1016/j.biotechadv.2009.05.008
  17. Hossler, P., Khattak, S. F., and Li, Z. J. 2009. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology 19, 936-949. https://doi.org/10.1093/glycob/cwp079
  18. Wu, S. C. 2009. RNA interference technology to improve recombinant protein production in Chinese hamster ovary cells. Biotechnol. Adv. 27, 417-422. https://doi.org/10.1016/j.biotechadv.2009.03.002
  19. http://www.envtimes.co.kr/view.asp?seq=2009070201
  20. http://www.hkn24.com/news/articleView.html?idxno=41229
  21. Jang, J., Hong, S. H., Choi, D., Choi, K. S., Kang, S., and Kim, I. H. 2010. Overexpression of Newcastle disease virus (NDV) V protein enhances NDV production kinetics in chicken embryo fibroblasts. Appl. Microbiol. Biotechnol. 85, 1509-1520. https://doi.org/10.1007/s00253-009-2189-z
  22. 정부 정책 변화와 국내 백신의약품 시장 전망. 2005. 하나금융경영연구소.